India  

Third dose of Covaxin gets nod for trials, six months after 2nd shot

Indian Express Thursday, 1 April 2021 ()
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Pfizer Is Studying the Effects of a Third COVID-19 Vaccine Dose [Video]

Pfizer Is Studying the Effects of a Third COVID-19 Vaccine Dose

Pfizer Is Studying the Effects of a Third COVID-19 Vaccine Dose. Two doses of Pfizer's COVID-19 vaccine have proven to be 95% effective at preventing severe coronavirus infection. On Feb. 25, the..

Credit: Wibbitz Top Stories     Duration: 01:05Published

Related news from verified sources

Covid-19: Government's expert panel allows clinical trials for third dose of Covaxin

Bharat Biotech presented amendments to the subject expert committee of the Drugs Controller General of India (DCGI) in the approved Phase 2 clinical trial...
IndiaTimes